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a b s t r a c t
Cerebral vasospasm (CVS) is a life-threatening condition that occurs in a large proportion of those
affected by subarachnoid haemorrhage and stroke. CVS manifests itself as the progressive narrowing of
intracranial arteries. It is usually diagnosed using Doppler ultrasound, which quantifies blood velocity
changes in the affected vessels, but has low sensitivity when CVS affects the peripheral vasculature.
The aim of this study was to identify alternative biomarkers that could be used to diagnose CVS. We used
a 1D modelling approach to describe the properties of pulse waves that propagate through the cardiovas-
cular system, which allowed the effects of different types of vasospasm on waveforms to be characterised
at several locations within a simulated cerebral network. A sensitivity analysis empowered by the use of a
Gaussian process statistical emulator was used to identify waveform features that may have strong cor-
relations with vasospasm. We showed that the minimum rate of velocity change can be much more effec-
tive than blood velocity for stratifying typical manifestations of vasospasm and its progression. The
results and methodology of this study have the potential not only to improve the diagnosis and monitor-
ing of vasospasm, but also to be used in the diagnosis of many other cardiovascular diseases where car-
diovascular waves can be decoded to provide disease characterisation.
Crown Copyright  2019 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Among the complications of subarachnoid haemorrhage (SAH)
and stroke, cerebral vasospasm (CVS) is the leading cause of cere-
bral ischemia which leads to death of cerebral tissue cells (Fehnel
et al., 2014; Macdonald, 2016). CVS manifests itself in the gradual
contraction of intracranial arteries, resulting in a narrowed lumen,
and initiates days after SAH. The effects of cerebral ischemia typi-
cally become evident after one week. Each year, SAH occurs in
between 8 and 10 out of every 100,000 adults, of whom approxi-
mately 50% go on to develop CVS, which often results in long-
lasting neurological impairment or death (British Society of
Neurological Surgeons, 2006; Pluta et al., 2009).
The mechanism behind SAH-induced CVS is not completely
understood. Several pathological mechanisms have been suggested
to explain CVS, including changes in vascular responsiveness, and
inflammatory or immunological responses of the vascular wall
(Lin et al., 2014). Currently, Transcranial Doppler ultrasound
(TCD) is the most commonly used diagnostic tool (Kumar et al.,
2016). In patients with CVS, TCD typically shows an increase in
blood velocity from baseline values in the affected vessels (Aaslid
et al., 1984; Fontana et al., 2015; Harders and Gilsbach, 1987). This
biomechanical metric (henceforth referred to as a biomarker)
effectively detects CVS in larger arteries, but its sensitivity
decreases when CVS affects vessels concealed behind thick bone
tissue in the peripheral intracranial vasculature. As a result, CVS
is commonly diagnosed by excluding other possible causes and
there is a need for more effective diagnostic biomarkers.
Pulse waves in the cardiovascular system originate from peri-
odic contraction of the heart, and propagate through the elastic
vessels of the cardiovascular system. These waves reflect at sites
of mechanical discontinuity, such as bends, bifurcations, or sudden
narrowing, including those caused by vasospasm. Numerical
models, in particular 1D and 0D-distributed models, have been
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successfully used to capture and describe the physics of propaga-
tion of these waves (Alastruey et al., 2007; Reymond et al., 2009).
Several computational models have been proposed to better
understand the cause-effect mechanisms governing CVS (Baek
et al., 2007; Lodi and Ursino, 1999; Robinson et al., 2010). In these
studies, CVS was assumed to affect only the middle cerebral artery
(MCA) and the focus was on the currently used biomarker, blood
flow velocity, showing its increase in the narrowing vessel. To
the authors’ knowledge, there is no evidence in the literature of
studies that link CVS in different locations (including the periph-
eral circulation) to pulse waveform features measured proximally.
The construction of patient-specific 1D cardiovascular system
models is also challenging because the model inputs (anatomical
parameters, boundary conditions, and initial conditions) are diffi-
cult or expensive to measure in the clinical setting. It is therefore
important to ensure that biomarkers and model predictions are
robust under a range of plausible model inputs. An extensive
exploration of the model input-space is computationally intensive
because the model must be run many times with different sets of
inputs, but can be made tractable by replacing the mechanistic
numerical model with a fast-running emulator. The most com-
monly used emulation methods are Gaussian process and polyno-
mial chaos expansions (PCE) (Donders et al., 2015; O’Hagan, 2013).
In a previous study, we used a Gaussian process (GP) to emulate a
1D cardiovascular system model to a high level of accuracy (Melis
et al., 2017). We showed how the GP emulator could reduce the
computational cost of model runs by 95%. A GP emulator can treat
inputs and outputs explicitly as uncertain quantities, and so by
determining the proportion of output variance that could be
accounted for by each uncertain input we were able to calculate
variance based sensitivity indices for each input and output of
the model.
The aims of the present study were to (i) develop a 1D numer-
ical biomechanical model of blood flow in the cerebral circulation,
(ii) build a GP emulator of this model, (iii) use the emulator to
examine the effect of simulated CVS with varying severity and
extension on the properties of the pulse waveform, and (iv) to
identify biomarkers that show the greatest sensitivity to the pres-
ence and extent of CVS. In the wider context, the present study
describes the use of sensitivity indices as a way to identify effective
biomarkers, which is a novel approach that has the potential to
result in clinically useful tools.
2. Materials and methods
The study consisted of the following steps:
1. Complete network model: implementation of an arterial network
model including vessels typically affected by CVS (complete
model).
2. Biomarker-pool selection: identification of pulse waveform
descriptors.
3. Sensitivity analysis: development of a Gaussian process emula-
tor using a reduced number of model runs evenly distributed
across the input parameter-space. The resulting GP was then
used to run a full sensitivity analysis (SA) of the complete model
outputs of interest to the input parameters of interest, i.e. vessel
radii reduction.
4. CVS simulation: The 1D model was reduced to include only the
internal carotid artery (ICA) and its peripheral vessels (reduced
model) and employed to simulate CVS with different degrees of
severity. The model reduction was done to ensure a constant
perfusion of the arteries affected by CVS, and to include the
effect of vascular autoregulation. The reduced model included
the left ICA, anterior cerebral artery (ACA), and the MCA with
its peripheral ramifications. The results of this second set of
simulations were then analysed to establish a relation between
biomarkers and CVS properties w.r.t. traditional biomarker.
2.1. Complete network model
The numerical model used to simulate the propagation and
reflection of pulse waveforms in typical vascular networks,
together with its validation is described in Melis et al. (2017) and
Melis (2017). Briefly, the model is based on the reduced 1D form
of the general continuity and Navier-Stokes equations for incom-
pressible flows within narrow straight elastic tubes. The model
assumes a flat velocity profile to compute the convective term
(which goes to zero) and a parabolic profile for viscous losses.
The model outputs are pressure, flow rate, and velocity waveforms.
These are time- and space-dependent signals with period T equal
to the cardiac cycle (T ¼ 0:8 s). A constitutive equation taking into
account the elastic wall behaviour is used to close the equation
system whose mechanical properties are set to resemble physio-
logical values for healthy subjects.
The vascular network employed in this study is made of 61 ves-
sels connected in a tree-like configuration (Fig. 1). It starts from the
ascending aorta and includes the entire circle of Willis and a
detailed description of the MCA daughter branches. The mechani-
cal properties of the arteries were taken from Reymond et al.
Fig. 1. Diagram of the complete cerebral vascular network model. The network
begins from the ascending aorta and includes all the main arteries in the circle of
Willis (brain area). The reduced MCA network (red vessels) includes the ICA (inlet
vessel), ACA, and MCA bifurcation and the vessels branching out the MCA. (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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(2009) as representative of a generic young and healthy subject
(Table 1). The circle of Willis network from Alastruey et al.
(2007) was extended to include the detailed anatomical descrip-
tion of MCA branches with data from Gibo et al. (1981) and
Tanriover et al. (2003).
The numerical solution of the complete network model was
computed by means of openBF (Melis, 2018), a finite-volume sol-
ver for 1D networks of elastic vessels. Pressure, flow, and velocity
waveforms were obtained along five equispaced locations in each
vessel. The inlet boundary condition at ascending aorta was set
as a typical volumetric flow rate waveform taken from Alastruey
et al. (2007) (Fig. 2(a)), and the outlet boundary conditions were
set by coupling each 1D model outlet with a three-element Wind-
kessel model of the peripheral vasculature, with typical peripheral
resistance and compliance values taken from Alastruey et al.
(2007). In order to reduce unrealistic reflections, the first Wind-
kessel resistance value R1 was changed at each time step to match
the 1D segment impedance. The second resistance R2 was then
calculated so that R1 þR2 ¼ Rp, where Rp was the peripheral
resistance set to a constant value that matched typical resistances
Table 1
Cerebral circulation mechanical properties. Posterior communicating artery (PCoA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA),
anterior communicating artery (ACoA).
ID Artery ‘ (cm) R0 (cm) E (kPa) R1 þR2 (10
9 Pasm3) Cp (10
10 m3Pa1)
1 Ascending aorta 4.00 1.200 400 – –
2 Aortic arch I 2.00 1.120 400 – –
3 Brachiocephalic 3.40 0.620 400 – –
4 Aortic arch II 3.90 1.070 400 – –
5 Common carotid L 20.8 0.250 400 – –
6 Common carotid R 17.7 0.250 400 – –
7/9 Subclavian 3.40 0.423 400 – –
8 Thoracic aorta 15.6 0.980 400 0.180 38.70
10/13 Ext. carotid 17.7 0.150 800 5.430 1.273
11/12 Int. carotid I 17.7 0.200 800 – –
14/17 Vertebral 14.8 0.136 800 – –
15/16 Brachial 42.2 0.403 400 2.680 2.584
18/21 Int. carotid II 0.50 0.200 1600 – –
19/20 PCoA 1.50 0.073 1600 – –
22 Basilar 2.90 0.162 1600 – –
23/24 MCA 11.9 0.143 1600 – –
25/26 ACA I 1.20 0.117 1600 – –
27/28 PCA I 0.50 0.107 1600 – –
29/30 ACA II 10.3 0.120 1600 8.480 0.821
31 ACoA 0.30 0.074 1600 – –
32/33 PCA II 8.60 0.105 1600 11.08 0.622
34/48 Sup. trunk MCA I 6.81 0.113 2400 – –
35/49 Sup. trunk MCA II.I 5.50 0.100 2400 – –
36/50 Orb. frontal 5.10 0.072 2400 6.401 0.113
37/51 Prefrontal 3.64 0.071 2400 6.400 0.113
38/52 Sup. trunk MCA II.II 3.40 0.101 2400 – –
39/53 Central 3.71 0.070 2400 3.380 0.201
40/54 Angular 21.0 0.701 2400 2.502 0.275
41/55 Inf. trunk MCA I 4.00 0.113 2400 – –
42/59 Inf. trunk MCA II.I 3.56 0.110 2400 – –
43/61 Temp. occipital 9.20 0.775 2400 2.155 0.320
44/60 Mid. temp. 8.91 0.717 2400 3.464 0.199
45/56 Inf. trunk MCA II.II 3.76 0.100 2400 – –
46/58 Ant. temp. 9.50 0.715 2400 4.011 0.172
47/57 Temp. pol. 7.80 0.712 2400 5.523 0.123
Fig. 2. Time dependent inlet volumetric flow rate functions at the ascending aorta (a) and internal carotid artery (b).
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of the distal capillary network at that location. The vessel impe-
dance was then computed as q c=A0, where q was the constant
blood density, c the pulse wave velocity (which is a function of
the lumen diameter A ¼ Aðx; tÞ and vessel compliance), and A0
the constant reference lumen diameter (Table 1).
2.2. Biomarker-pool selection
We selected potential biomarkers as waveform features that
would be easy to extract in the clinical context, and those that
are commonly used to calculate more complex metrics such as
the augmentation and pulsatility indices. The biomarker-pool
therefore consisted of minimum, maximum, and time average in
one cardiac cycle (minðÞ; maxðÞ, and meanðÞ, respectively) of
velocity (u) and pressure (P) waveforms, along with their first time
derivatives (ut and Pt , respectively).
2.3. Sensitivity analysis
SA was performed to identify the set of outputs most sensitive
to a change of each single input of the numerical model (Melis
et al., 2017). In a highly non-linear vascular model, waveforms
may be sensitive to more than one model parameter or combina-
tions of them. Hence, only outputs highly sensitive to changes in
lumen radius were selected as CVS biomarkers. SA was per-
formed considering for each vessel the lumen radius (R0) and
its length (‘), the wall’s Young’s modulus (E), and the peripheral
resistance and compliance of the Windkessel models at the
outlets (Rp, and Cp). We computed the sensitivity to Rp because
this remained constant throughout each model run, whereas the
individual Windkessel resistances R1 and R2 changed at each
time step.
SA was done by means of the analysis of variance decomposi-
tion (equation 11 in Saltelli et al. (2010)) from which Sobol’s sen-
sitivity indices were computed (Saltelli et al., 2010; Sobol, 2001)
using the method described in our earlier work (Melis et al.,
2017), where the numerical model is replaced by a fast-running
GP emulator (Melis et al., 2017; Oakley and O’Hagan, 2004;
O’Hagan, 2006). The GP emulator had a zero mean and a squared
exponential kernel as described in our earlier paper (Melis et al.,
2017), and the GP was fitted using the inputs and outputs from
an initial set of 50 numerical simulations as described below.
The sensitivity indices measure the contribution to variance in
each model output (i.e., variance of a waveform biomarker) from
the variance of each model input (first-order indices), or from the
interaction of one input with other inputs (total-order indices).
By definition, Sobol’s indices are in the ½0;1 interval; in the case
of first-order indices, Si;j ¼ 0 indicates that none of the output j
variance can be ascribed to input i, and Si;j ¼ 1 indicates that the
output j variance depends only on input i. The interactions
between inputs are taken into account by total-order indices, and
the difference between total- and first-order indices returns
higher-order indices, Hj. For example, Hi;j > 0 indicates that the
output j variance is influenced by the interaction between input i
and other input variables. The aim of SA in this case is to identify
those model outputs sensitive to changes in radius (high first-
order indices w.r.t. input R0) but not to input interactions. The
model outputs satisfying these conditions were selected as CVS
biomarkers; the SA was performed in four steps:
All model inputs were initialised with typical reference values
(Table 1) and then changed within 50% of their reference values
as such variation is plausible for the CVS scenario (Findlay et al.,
2016). A homogeneous coverage of the input space was ensured
by the use of Latin hypercube sampling method as explained in
Melis et al. (2017).
1. A set of 50 input parameter points was identified by the Latin
hypercube sampling from uniform distributions of each model
input in the range 50% of typical reference values given in
(Table 1). A set of numerical simulations run using these inputs
were used to train the GP emulator. Latin hypercube sampling
ensured an even coverage of the input space, and the number
of training runs was based on our earlier experience (Melis
et al., 2017).
2. The GP emulator was trained using normalised inputs and out-
puts from the training data, and its hyper-parameters optimised
via the stochastic gradient descent method. The number of GP
hyper-parameters was twice the number of inputs.
3. The trained GP emulator was used to generate the predictions
on the Oðd 103Þ (where d is the number of inputs) input set.
4. Sobol’s sensitivity indices were computed from these outputs
and converted to percent values. The outputs were ranked
accordingly to the values of their indices with respect to the
radius. In addition, the higher-order indices were computed
and used to ensure that only features sensitive to R0 were
selected.
The GP emulator was trained on a set of 50 1D numerical model
runs, and was validated against an additional set of 200 model
runs. To assess the error made by the GP on predicting numerical
outcomes, the mean average prediction error (MAPE) was com-
puted as
MAPE ¼
100
N
XN
i¼1
jY i  yij
Y i
; ð1Þ
where N is the total number of input points, and Y i and yi are the i
th
output from the numerical model and from the GP emulator,
respectively.
2.4. CVS simulations
To simulate CVS, we used a reduced network model. The
reduced model starts from the internal carotid artery and bifur-
cates into the ACA and the MCA (segments 18, 25, and 23 in
Fig. 1, respectively). The inlet boundary condition at the ICA root
was set as a typical volumetric flow rate from Alastruey et al.
(2007) (Fig. 2(b)). The ACA was included to consider the effect of
flow redistribution caused by the CVS and it was closed by a
three-element Windkessel model, whereas all the distal vascula-
ture past the MCA was included to simulate the effect of CVS.
The propagation and narrowing levels of vasospasm was
decided in consultation with two fully trained Interventional Neu-
roradiologists from University Hospital of Tours, Tours, France.
Various CVS types describing the progression of CVS were consid-
ered. These included either CVS spreading from the MCA towards
periphery (forward CVS) or from the periphery towards the MCA
(backward MCA) in a symmetric or asymmetric configuration
(Fig. 3). In all the configurations, the lumen diameter reduction
was gradually increased in six stages from the baseline condition
(0%) to severe vasospasm (60% of vessel narrowing). Narrowing
was uniform across the lumen, with no change in vessel shape.
3. Results
3.1. Complete network model and GP emulator validation
The complete network model was validated against results
reported in Alastruey et al. (2007) to ensure correct parameterisa-
tion of the additional vessels. The waveforms calculated by the two
models match at several locations within the system (Fig. 4a).
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The complete network model was further validated by compar-
ing predicted velocity values time-averaged over the cardiac cycle
in the MCA, and in the presence of vasospasm, with published
measurements from SAH patients (Sloan et al., 1989) (Fig. 4b).
The complete network model is in good agreement with literature.
Discrepancies are smaller than 7% for lumen diameter reduction
< 50%; for narrowing > 50%, the complete network model predic-
tions diverge from the experimental measurements (30% differ-
ence at 60% narrowing).
The GP emulator, trained upon 50 simulator runs, was validated
against an additional set of 200 simulations. The comparison of
numerical results and GP predictions is reported in Fig. 4c where
the points scattered along the diagonal line of equality indicate a
good agreement between simulations and emulator predictions.
The MAPE scored on the test-set was 3:53%, which is small with
respect to the 300% whole biomarker variation within the CVS
range.
The total simulation time using the complete network model
for the 50 point dataset used for emulator training was equal to
31 h on a standard Linux workstation. The emulator training and
the SA on the complete d 103 dataset were performed in 10:4 s.
The total computational time estimated to perform a complete
Monte Carlo analysis using the complete network model would
have required approximately 612 h. Therefore, the entire SA by
means of GP emulator took 5% of the Monte Carlo computational
time.
3.2. SA and CVS biomarkers selection
The sensitivity analysis results are reported in terms of Sobol’s
sensitivity indices (Fig. 5a). The total and first-order sensitivity
indices were converted to percentage (i.e. sensitivity indices were
multiplied by 100) and reported in bar charts (Fig. 5) as plain and
hatched bars, respectively. For instance, the SA indicates that the
mean value of the pressure waveform is more sensitive to changes
in peripheral resistance (Rp) than in peripheral compliance at the
set heart rate (Cp in Fig. 5c). The velocity first time-derivative is
highly sensitive to changes in lumen radius (R0, Fig. 5b); in partic-
ular, the minimum value of the velocity time-derivative is exclu-
sively dependent on the changes in radius as the difference
between first- and total-order indices is 1%. Therefore, in the fol-
lowing analysis, the effectivity of min(ut) as a CVS biomarker is
tested.
3.3. CVS simulations
Results are presented as percent changes of the selected CVS
biomarkers with respect to the pre-vasospasm value (C%). For dif-
ferent levels of vessel narrowing, the C% was computed as
CðxÞ ¼ 100
xCVS
xREF
 1
 
; ð2Þ
where xCVS is the value of the CVS biomarker as the CVS is occurring
and xREF is the value of the CVS biomarker in the pre-vasospasm
configuration.
The results in terms of time average and minimum first time-
derivative velocity biomarkers for proximal and distal CVS are
reported in Fig. 6. The meanðuÞ biomarker is sensitive to small
changes in MCA radius as it increases by 50% for 20% lumen radius
decrease (Fig. 6a). The minðutÞ biomarker is less sensitive to prox-
imal changes in radius and it decreases by 50% only for severe CVS
(lumen reduction > 50%). Conversely, in case of peripheral CVS
(Fig. 6b), the meanðuÞ biomarker slowly decreases as the lumen
radius decrease and a change of 50% is obtained for severe CVS
(lumen reduction 60%). The minðutÞ biomarker change is more
sensitive to peripheral CVS as a 50% increase is obtained for 30%
lumen reduction in any CVS configuration. In the case of symmetric
CVS (circle marker), the increase in minðutÞ is of 75% for 20% diam-
eter reduction.
In an attempt to identify biomarkers capable of detecting vasos-
pasm from an early stage of inception the velocity biomarkers
(meanðuÞ and minðutÞ;meanðutÞ, and maxðutÞ) for 10% lumen
reduction for all CVS configurations are reported in Fig. 7. This
comparison highlights how different biomarkers can be used for
early detection of CVS occurring at different locations. The
meanðuÞ and meanðutÞ biomarkers show a 20% increase in all the
cases in which the MCA is affected by CVS (i.e., I; I þ II, and
I þ II þ III, in Fig. 7(a, c)), but they only decrease by 8% in case of
peripheral CVS (i.e., II þ III and III cases). On the other hand, the
minðutÞ biomarker increases of at least 10% in the peripheral CVS
cases (Fig. 7b). The maxðutÞ biomarker changes are lower than
5% in all the simulated cases (Fig. 7d).
Fig. 3. Cerebral vasospasm simulation configurations. The arteries branching out the MCA have been divided in three generations (I, II, and III). In each configuration, the
vessels affected by CVS are coloured in red and those not affected in grey. Additionally, the CVS could propagate along both superior (Sup.) and inferior (Inf.) MCA branches
(Full symmetric configuration) or only along the superior or inferior one (asymmetric case). Finally, the CVS could propagate either from MCA to periphery (forward CVS) or
from peripherical vessels towards the MCA (backward CVS).
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4. Discussion
The aim of this study was to identify more efficient biomarkers
capable of characterising different types of CVS and allow its early
detection.
A 1D model of the cerebral circulation was developed to
describe the physics of wave propagation through a typical vascu-
lar network and to predict the effects of vasospasm on waveforms.
A pool of CVS biomarkers was identified through SA on waveform
features. The biomarkers examined were pulse waveform features
whose variation is caused by changes in mechanical properties due
to CVS. A computationally efficient exploration of the parameter
space in a 1D model of the cerebral circulation was performed by
means of GP emulation.
Our modelling approach showed that a CVS occurring at the
measurement location caused an increase (more than 150% in sev-
ere cases) of meanðuÞ, as expected, and validated by clinical obser-
vations. However, when the CVS occurred more peripherally
(Fig. 8), meanðuÞ was only marginally affected by the vessel lumen
reduction and was effective only for severe levels of vessel narrow-
ing (it decreased by 47% when vessel narrowing was 50%). The
decrease was due to the increase in peripheral resistance and, in
turn, to the flow diversion towards the distal ICA. This demon-
strates that meanðuÞ cannot be a good diagnostic predictor for
CVS in distal arteries. Conversely, the minimum gradient of the
velocity waveform (minðutÞ) was more sensitive to CVS affecting
distal arteries. An increase (up to 155%) of this biomarker occurred
for all the CVS configurations tested. Thus we propose that minðutÞ
has potential diagnostic value for CVS in distal arteries.
The influence of vessel narrowing on the decelerating part of
the pulse waveform is what would be expected from simple
biomechanical considerations. From the Moens-Korteweg equation
(relating wave speed to lumen and other mechanical properties),
reduction in lumen diameter will result in a higher wave propaga-
tion speed of the reflected waves through the narrowed sections,
which in turn will result in an ’earlier’ superposition of the
reflected wave on the incident waves and therefore on changes
to the decelerating slope of the proximally measured waveform.
Minimum ðutÞ occurs immediately after peak systole, when there
is superposition of both incident and backward travelling waves.
Fig. 4. (a) Validation of extended cerebral vasculature model. Velocity waveforms computed by openBF for the model presented in Figure 1 are compared with waveforms
published in Alastruey et al. (2007) and computed in a network without the extended MCA description. (b) Comparison of velocity change in the MCA against percentage
lumen diameter reduction for the current study (continuous line) and published experimental measurements (dashed line) (Sloan et al., 1989). (c) Comparison between the
GP emulator predictions and the mechanistic model outputs: points lying along the line of equality indicate good agreement between the two methods.
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Fig. 5. Sensitivity indices for u and P biomarkers against variations of the model input parameters (R0 lumen radius, ‘ vessel length, E Young’s modulus, Rp peripheral
resistance, and Cp peripheral compliance). Each plot shows sensitivity indices for each input. The hatched section of the bars show the first-order sensitivity indices, and the
plain sections the total-order indices. Thus the height of the hatched bar shows the biomarker sensitivity to a single input and the plain section the sensitivity to multiple
inputs.
Fig. 6. Percent change of CVS biomarkers as the lumen radius decreases in the case of CVS occurring at MCA (a) and in peripheral arteries (b). Both symmetric (circular
marker) and asymmetric (triangular makers) CVS cases are reported. The Full CVS configurations and the waveforms measurement point (black cross) are reported in the
lower sketches.
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Backward waves are produced by mechanical discontinuities such
as a change in radius, and so we would speculate that minðutÞ
responds to changes in the backward waves relative to the incident
wave. Further numerical and experimental work would be needed
to establish if this is the case.
Overall, our velocity biomarker results were in agreement with
previously published experimental work where an increase in
meanðuÞ was associated with a decrease in MCA lumen diameter.
However, while the numerical model accurately predicted the
velocity biomarkers, it lacks a detailed and mechanistic represen-
tation of the autoregulation system that is believed to play an
important role in the response of the cardiovascular system after
haemorrhagic events. In this study, cerebral autoregulation was
simulated in an indirect fashion, by imposing a constant flow rate
at the inlet of a reduced network. Therefore, a further study
should include the entire vascular network (i.e., the whole circle
of Willis and both sides of the cerebral circulation) and a dynamic
representation of the autoregulation mechanism to ensure a
direct estimation of the effects of an extended network on wave-
forms. This network could also be used to identify better mea-
surement locations for monitoring early CVS onset and
progression. Alongside, the numerical results described in the
present study can be used as hypothesis to inform experimental
measurements, and to validate the newly found biomarker pre-
diction accuracy.
Fig. 7. Velocity biomarkers for CVS onset (lumen reduction 10%). Depending on the CVS configuration, different velocity waveform features can be used. CVS including the
main MCA branch (first generation, I) causes an increase inmeanðuÞ andmeanðutÞ, while peripheral CVS (second and third generation, II and III) causes the increase inminðutÞ.
Fig. 8. Comparison between the current CVS biomarker (meanðuÞ) and the proposed
biomarker (minðutÞ) for the peripheral CVS case. A change in 50% of the minðutÞ
biomarker occurs for small changes in lumen diameter (15%) whereas the meanðuÞ
biomarker decreases of 50% only in the case of severe vasospasm (60% diameter
reduction).
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The proposed mechanistic model can be used to describe pres-
sure waveforms in transcranial arteries affected by CVS. This model
was used to identify more sensitive CVS biomarkers than those
currently used in clinical practice. In particular, the mean velocity
measured by TCD does not detect distal CVS whereas the minimum
gradient of the velocity waveform is capable of differentiating
between location and severity of CVS. However, the model used
in the present study assumes flat and parabolic velocity profiles
for the convective term an viscous losses respectively, and these
assumptions may be an important factor that determines whether
the CVS biomarkers identified in this study can be used effectively
in the clinical setting.
Nevertheless, this study, once clinically validated, has the
potential to guide development of better monitoring and diagnos-
tic protocols and technologies for a more effective management of
patients not only in the context of vasospasm, but in the treatment
of many other cardiovascular diseases, whose presence and pro-
gression may be decoded in a similar fashion to provide disease
characterisation.
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